Assessment of bronchoprovocation test positivity and response to montelukast theraphy in chronic urticaria patients

Y. Havlucu, D. Y. Havlucu, S. Ozturkcan, A. Yorgancioglu (Manisa, Turkey)

Source: Annual Congress 2006 - Bronchial asthma – issues in inflammation, prevention and management
Session: Bronchial asthma – issues in inflammation, prevention and management
Session type: Thematic Poster Session
Number: 2592
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Havlucu, D. Y. Havlucu, S. Ozturkcan, A. Yorgancioglu (Manisa, Turkey). Assessment of bronchoprovocation test positivity and response to montelukast theraphy in chronic urticaria patients. Eur Respir J 2006; 28: Suppl. 50, 2592

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of antileukotriene therapy on methacholine challenge test in patients with mild asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Does acute bronchodilator test is predictive of inhaled corticosteroid response in COPD/asthma patients?
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010

Bronchial challenge test in patients with chronic persistent cough and asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 475s
Year: 2003

Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough
Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma
Year: 2006

Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough
Source: Annual Congress 2009 - Accuracy in lung function testing
Year: 2009

Tolerance test for inhaled antibiotics in patients with chronic bronchial infection
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



Response to tuberculin test in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 116s
Year: 2002

Evaluation of therapeutic response to anti-IL5 treatment in severe eosinophilic asthma patients no responders to omalizumab
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019


Does positive bronchodilator reversibility testing predict positive bronchoprovocative methacholine challenge testing in suspected asthma patients
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


Improvement in symptoms, wheezing and pulmonary function tests of asthmatic patients due to application of GINA in their treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 842s
Year: 2006

Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Efficacy of short-term high dose predonisolone therapy in acute exacerbation of bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 71s
Year: 2001

Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003

Comparison of exercise provocation and induced sputum measurement in patients with positive methacholine provocation test
Source: Eur Respir J 2005; 26: Suppl. 49, 371s
Year: 2005

Inhaled budesonide suppresses airway and systemic eosinophilic inflammation in COPD. No predictive value of a prednisolone test treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005

Evaluation of the individual bronchodilator response in patients with severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

Oral montelukast in patients with acute severe asthma
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007


Montelukast and budesonide therapy of asthmatic patients suffering from chronic cough
Source: Eur Respir J 2006; 28: Suppl. 50, 440s
Year: 2006

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
Source: International Congress 2017 – Asthma management
Year: 2017

Esomeprazole 80 mg single-dose improves the bronchial response to MCh in non atopic GER-related asthma
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005